(DCI) Donaldson - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 9.607m USD | Total Return: 20.7% in 12m
Avg Turnover: 43.9M
EPS Trend: 97.8%
Qual. Beats: -1
Rev. Trend: 97.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Donaldson Company, Inc. (NYSE: DCI) is a global manufacturer of filtration systems and replacement parts, operating through Mobile Solutions, Industrial Solutions, and Life Sciences segments. The company serves a diverse range of end-markets, including construction, mining, aerospace, defense, and bioprocessing. Its product portfolio encompasses air and liquid filtration, emissions systems, and specialized membrane-based products for high-tech manufacturing.
The company utilizes an aftermarket-heavy business model, where a large installed base of original equipment manufacturer (OEM) systems drives recurring revenue through the sale of proprietary replacement filters. In the industrial machinery sector, this razor-and-blade strategy often provides more stable cash flows compared to the cyclical nature of primary equipment sales. Donaldson’s expansion into Life Sciences reflects a strategic shift toward high-margin technical applications, such as bioprocessing and semiconductor manufacturing.
Investors can further analyze these segment growth rates and valuation metrics on ValueRay. Founded in 1915 and headquartered in Minnesota, Donaldson maintains a significant global footprint with a distribution network spanning independent dealers, OEMs, and direct end-users.
- Aftermarket replacement part demand stabilizes recurring revenue and operating margins
- Global heavy-duty equipment production levels dictate Mobile Solutions segment performance
- Life Sciences expansion through bioprocessing acquisitions diversifies high-margin revenue streams
- Raw material price volatility and supply chain costs impact manufacturing profitability
- Industrial CAPEX spending cycles influence dust and fume collection system orders
| Net Income: 378.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -0.25 > 1.0 |
| NWC/Revenue: 22.95% < 20% (prev 18.07%; Δ 4.87% < -1%) |
| CFO/TA 0.14 > 3% & CFO 413.9m > Net Income 378.5m |
| Net Debt (504.5m) to EBITDA (626.3m): 0.81 < 3 |
| Current Ratio: 2.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.9m) vs 12m ago -2.88% < -2% |
| Gross Margin: 34.36% > 18% (prev 0.35%; Δ 3.40k% > 0.5%) |
| Asset Turnover: 124.6% > 50% (prev 122.7%; Δ 1.94% > 0%) |
| Interest Coverage Ratio: 19.14 > 6 (EBITDA TTM 626.3m / Interest Expense TTM 27.6m) |
| A: 0.28 (Total Current Assets 1.53b - Total Current Liabilities 665.9m) / Total Assets 3.06b |
| B: 0.90 (Retained Earnings 2.75b / Total Assets 3.06b) |
| C: 0.18 (EBIT TTM 528.4m / Avg Total Assets 3.01b) |
| D: 2.26 (Book Value of Equity 3.36b / Total Liabilities 1.49b) |
| Altman-Z'' = 8.33 = AAA |
| DSRI: 1.05 (Receivables 647.9m/597.6m, Revenue 3.75b/3.63b) |
| GMI: 1.03 (GM 34.36% / 35.41%) |
| AQI: 0.95 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 1.03 (Revenue 3.75b / 3.63b) |
| TATA: -0.01 (NI 378.5m - CFO 413.9m) / TA 3.06b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of May 25, 2026, the stock is trading at USD 82.62 with a total of 492,035 shares traded.
Over the past week, the price has changed by +2.10%,
over one month by -5.96%,
over three months by -21.73% and
over the past year by +20.68%.
Donaldson has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold DCI.
- StrongBuy: 2
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 96.4 | 16.7% |
P/E Forward = 18.7617
P/S = 2.5601
P/B = 5.9962
P/EG = 1.5623
Revenue TTM = 3.75b USD
EBIT TTM = 528.4m USD
EBITDA TTM = 626.3m USD
Long Term Debt = 674.3m USD (from longTermDebt, last quarter)
Short Term Debt = 6.50m USD (from shortTermDebt, last quarter)
Debt = 698.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 18.1m
Net Debt = 504.5m USD (calculated: Debt 698.9m - CCE 194.4m)
Enterprise Value = 10.1b USD (9.61b + Debt 698.9m - CCE 194.4m)
Interest Coverage Ratio = 19.14 (Ebit TTM 528.4m / Interest Expense TTM 27.6m)
EV/FCF = 28.91x (Enterprise Value 10.1b / FCF TTM 349.7m)
FCF Yield = 3.46% (FCF TTM 349.7m / Enterprise Value 10.1b)
FCF Margin = 9.32% (FCF TTM 349.7m / Revenue TTM 3.75b)
Net Margin = 10.09% (Net Income TTM 378.5m / Revenue TTM 3.75b)
Gross Margin = 34.36% ((Revenue TTM 3.75b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 33.45% (prev 35.15%)
Tobins Q-Ratio = 3.30 (Enterprise Value 10.1b / Total Assets 3.06b)
Interest Expense / Debt = 3.95% (Interest Expense 27.6m / Debt 698.9m)
Taxrate = 20.67% (24.1m / 116.6m)
NOPAT = 419.2m (EBIT 528.4m * (1 - 20.67%))
Current Ratio = 2.29 (Total Current Assets 1.53b / Total Current Liabilities 665.9m)
Debt / Equity = 0.44 (Debt 698.9m / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 0.81 (Net Debt 504.5m / EBITDA 626.3m)
Debt / FCF = 1.44 (Net Debt 504.5m / FCF TTM 349.7m)
Total Stockholder Equity = 1.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.57% (Net Income 378.5m / Total Assets 3.06b)
RoE = 25.19% (Net Income TTM 378.5m / Total Stockholder Equity 1.50b)
RoCE = 24.28% (EBIT 528.4m / Capital Employed (Equity 1.50b + L.T.Debt 674.3m))
RoIC = 19.00% (NOPAT 419.2m / Invested Capital 2.21b)
WACC = 8.45% (E(9.61b)/V(10.3b) * Re(8.84%) + D(698.9m)/V(10.3b) * Rd(3.95%) * (1-Tc(0.21)))
Discount Rate = 8.84% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.22 | Cagr: -1.72%
[DCF] Terminal Value 75.23% ; FCFF base≈348.1m ; Y1≈352.9m ; Y5≈380.8m
[DCF] Fair Price = 45.81 (EV 5.81b - Net Debt 504.5m = Equity 5.31b / Shares 115.8m; r=8.45% [WACC]; 5y FCF grow 1.13% → 2.50% )
EPS Correlation: 97.81 | EPS CAGR: 10.05% | SUE: -1.78 | # QB: -1
Revenue Correlation: 97.92 | Revenue CAGR: 3.62% | SUE: -0.12 | # QB: 0
EPS current Year (2026-07-31): EPS=3.98 | Chg30d=+0.00% | Revisions=-67% | GrowthEPS=+8.1% | GrowthRev=+3.5%
EPS next Year (2027-07-31): EPS=4.37 | Chg30d=-0.23% | Revisions=-33% | GrowthEPS=+9.9% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: -67%